Error: Could not add to watchlist. X
+ Watchlist

Gilead Pharmasset LLC

VRUS:US
Acquired
VRUS:US was acquired by GILD:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.06
Market Cap (USD)
-
Shares Outstanding (m)
75.657
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Gilead Pharmasset LLC is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
Address
303-A College Road East
Princeton, NJ 08540
United States
Phone
1-609-613-4100
Show More